(Q83477667)

English

Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats

scientific article published on 01 August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Rosiglitazone ameliorates diabetic nephropathy by reducing the expression of Chemerin and ChemR23 in the kidney of streptozotocin-induced diabetic rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

diabetic nephropathy

1 reference

based on heuristic

inferred from title

author name string

Wenchao Hu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Qian Yu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Jie Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Demin Liu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1287-1293

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22350950%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

https://scigraph.springernature.com/pub.10.1007/s10753-012-9440-y

0 references

Insulin resistance and its treatment by thiazolidinediones

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current therapies and emerging targets for the treatment of diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thiazolidinediones plus metformin association on body weight in patients with type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elevated serum chemerin concentrations are associated with renal dysfunction in type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of inflammatory responses associated with NF-kappa B pathway in kidneys from diabetic rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical importance of an elevated circulating chemerin level in incident dialysis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of inflammatory cytokines in diabetes and its complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemokine-like receptor 1 (CMKLR1) and chemokine (C-C motif) receptor-like 2 (CCRL2); two multifunctional receptors with unusual properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transcriptome profiling and the pathogenesis of diabetic complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum levels of the adipokine chemerin in relation to renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin--a new adipokine that modulates adipogenesis via its own receptor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin contributes to inflammation by promoting macrophage adhesion to VCAM-1 and fibronectin through clustering of VLA-4 and VLA-5.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin is an independent marker of the metabolic syndrome in a Caucasian population--a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone improves insulin sensitivity with increased serum leptin levels in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antifibrotic effects of pioglitazone at low doses on the diabetic rat kidney are associated with the improvement of markers of cell turnover, tubular and endothelial integrity, and angiogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glomerular expression of thrombospondin-1, transforming growth factor beta and connective tissue growth factor at different stages of diabetic nephropathy and their interdependent roles in mesangial response to diabetic stimuli

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q83477667&oldid=2005992881"